The painful phenomenon known as "back labor" occurs in a client whose fetus is in what position?

A. deep tendon reflexes: Magnesium sulfate acts as a central nervous system depressant by blocking neuromuscular transmission. The loss or diminution of the patellar reflex is the first clinical sign of rising serum magnesium levels. Hourly assessment allows for the early detection of neuromuscular blockade before respiratory arrest occurs.

B. edema: While peripheral and facial edema are characteristic findings in preeclamptic patients, they do not fluctuate rapidly enough to require hourly monitoring. Tracking fluid shifts is important for long-term management of third-spacing and pulmonary risk. It is not a primary indicator used to titrate or detect magnesium toxicity.

C. respirations: Toxicity from magnesium sulfate leads to progressive depression of the diaphragm and intercostal muscles. A respiratory rate below 12 breaths per minute indicates a dangerous accumulation of the drug in the systemic circulation. This assessment is the most critical parameter for preventing fatal respiratory failure during infusion.

D. level of consciousness: Central nervous system depression manifests as somnolence, slurred speech, or a decreased Glasgow Coma Scale score. As magnesium levels exceed the therapeutic range of 4 to 7 mEq/L, the patient may become increasingly lethargic. Hourly neurological checks ensure the patient remains alert and responsive to stimuli.

E. heart rate: Magnesium can cause peripheral vasodilation and a slight decrease in blood pressure, but it does not typically cause acute, toxic changes in heart rate. Tachycardia or bradycardia are not sensitive or specific markers for magnesium overdose. Monitoring focus remains on the respiratory and neuromuscular systems instead.

F. urine output: Magnesium sulfate is excreted almost exclusively by the kidneys, necessitating adequate renal perfusion for safe administration. Oliguria, defined as less than 30 mL per hour, leads to rapid drug accumulation and subsequent toxicity. Monitoring output ensures the kidneys are clearing the medication at a safe rate.

A. diabetes and hypertension: While protein in the urine can indicate hypertension, glycosuria is specific for metabolic dysfunction like diabetes mellitus. Hypertension is a clinical sign measured by blood pressure, while the urine test screens for the resulting renal complications. The jargon PIH is more specific to pregnancy.

B. diabetes and PIH: Glycosuria serves as a screen for gestational diabetes, while proteinuria is a hallmark sign of Pregnancy Induced Hypertension or preeclampsia. Regular monitoring allows for early detection of these two common gestational morbidities. This prevents severe complications like eclampsia or diabetic ketoacidosis.

C. pyelonephritis and diabetes: Pyelonephritis is a kidney infection typically diagnosed via white blood cells and nitrites in the urine, not just protein. While glucose monitoring is correct for diabetes, protein is a less specific marker for acute infection. Screening focuses on chronic metabolic and vascular changes.

D. urinary tract infection and PIH: UTIs are screened for using leukocyte esterase and nitrites rather than glucose. While protein is relevant for PIH, the absence of glucose monitoring in this choice overlooks the screening for gestational diabetes. The standard prenatal battery covers both metabolic and hypertensive risks.